...
首页> 外文期刊>The Veterinary Clinics of North America. Food Animal Practice >Mannheimia haemolytica and Pasteurella multocida in Bovine Respiratory Disease How Are They Changing in Response to Efforts to Control Them?
【24h】

Mannheimia haemolytica and Pasteurella multocida in Bovine Respiratory Disease How Are They Changing in Response to Efforts to Control Them?

机译:Mannheimia haemolytica和Pasteurella多偶在牛呼吸道疾病中如何改变控制它们的努力?

获取原文
获取原文并翻译 | 示例
           

摘要

The bacteria Mannheimia haemolytica and Pasteurella multocida contribute to bovine respiratory disease (BRD), which is often managed with antimicrobials. Antimicrobial resistance in these bacteria has been rare, but extensively drug-resistant strains have recently become common. Routine antimicrobial use may be driving this resistance. Resistance spread is caused in part by propagation of strains harboring integrative conjugative elements. The impact of antimicrobial resistance on treatment outcomes is not clear, but clinical observations suggest that response to first treatment has decreased over time, possibly because of resistance. Clinicians should consider antimicrobial resistance when designing BRD treatment and control programs.
机译:细菌Mannheimia Haemolytica和Pasteurella Multocida有助于牛呼吸道疾病(BRD),其通常用抗微生物进行管理。 这些细菌中的抗微生物抗性已经罕见,但最近耐药菌株的耐药菌株最近是常见的。 常规抗微生物使用可能是驱动这种阻力。 抗性扩散是部分通过携带整合缀合元素的菌株的繁殖引起的。 抗微生物抗性对治疗结果的影响尚不清楚,但临床观察表明对第一次治疗的反应随着时间的推移而降低,可能是因为抗性。 临床医生应在设计BRD治疗和控制计划时考虑抗微生物阻力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号